kampirone has been researched along with Anxiety in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moser, PC | 1 |
| Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN | 2 |
| Goncharenko, NV; Krivobok, GK; Pankrat'ev, DV; Talalaenko, AN | 1 |
4 other study(ies) available for kampirone and Anxiety
| Article | Year |
|---|---|
An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
Topics: Animals; Anxiety; Behavior, Animal; Buspirone; Diazepam; Fenclonine; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1989 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine | 2003 |
Neurochemical mechanisms of the dorsal pallidum in the antiaversive effects of anxiolytics in various models of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Biogenic Amines; Chlordiazepoxide; Fear; gamma-Aminobutyric Acid; Globus Pallidus; Glutamic Acid; Harmine; Male; Microinjections; Neurotransmitter Agents; Piperazines; Pyrimidines; Rats; Statistics, Nonparametric | 2006 |
[Neurochemical characteristics of the ventromedial hypothalamus and anti-aversive effects of anxiolytic agents in various anxiety models].
Topics: Adrenergic alpha-Antagonists; Amino Acids; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Biogenic Monoamines; Chlordiazepoxide; Dopamine D2 Receptor Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Harmine; Hypothalamus, Middle; Microinjections; Piperazines; Pyrimidines; Rats; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Serotonin Agents | 2001 |